Results
Weight loss injections before and after: realistic results
July 23, 2026 · 2 min read

The short answer
Weight loss injection results vary by drug: in trials, tirzepatide (Zepbound) averaged around a fifth of body weight lost on the highest dose, semaglutide (Wegovy) somewhat less, and liraglutide (Saxenda) less again, all over roughly a year or more.
Before-and-after photos are selective and usually show the far end near the finish line. Individual results depend on the drug and dose, diet, activity, and time on treatment. A realistic month-by-month picture is more useful than any single comparison.
What the trials actually show, by drug
"Weight loss injections" covers several different medications, and their average results differ, which is the first thing the dramatic before-and-after photos hide. Across their main trials, on the highest doses and over roughly a year or more:
- Tirzepatide (Zepbound, Mounjaro) averaged around 20 percent of body weight lost, the largest of the group.
- Semaglutide (Wegovy, Ozempic) averaged somewhat less, in the mid-teens percent.
- Liraglutide (Saxenda) averaged less again, though still meaningful, on a daily injection.
So a realistic before-and-after depends heavily on which injection you are on. Our semaglutide vs tirzepatide post and Saxenda vs Wegovy post compare them.
A realistic timeline
Whatever the drug, results build gradually rather than in the first weeks, because these injections are titrated up slowly:
- Month 1: Usually little visible change on the low starting dose. Some early loss can be water.
- Months 2 to 3: As the dose climbs, appetite falls more and the trend becomes clearer.
- Months 4 to 6: Often the steadiest stretch, where before-and-after differences become obvious.
- Months 6 to 12+: Loss continues but slows toward a plateau. The trial-level results come from staying the course.
Why photos are misleading
Before-and-after images vary enormously because the inputs vary: the drug and dose, starting weight, protein and diet, activity and resistance training (which protects muscle and shapes the result), sleep, and how long someone stayed on treatment. Photos are also selective and flattered by lighting, posture, and clothing. Comparing your week 6 to someone's month 14 on a different drug is not fair. Our brand-specific posts, like Zepbound before and after, tirzepatide before and after, and Mounjaro before and after, break each down.
Track your own before and after
The most useful comparison is you versus you. Weigh under consistent conditions, take monthly photos in the same light and pose, and log your dose alongside weight so you can see how your body responds to each step-up. Protecting muscle with protein and resistance training changes how the "after" looks, not just the number. DoseLog keeps dose, weight, and photos together so your progress stays honest. This article is general information, not medical advice.

Questions people ask
How much weight can you lose with weight loss injections?
It depends on the drug: in trials, tirzepatide (Zepbound) averaged around 20 percent of body weight on the highest dose, semaglutide (Wegovy) somewhat less, and liraglutide (Saxenda) less again, all over roughly a year or more. Individual results vary widely.
How long do weight loss injections take to show results?
Most people see little in month one on the low starting dose, clearer changes by months two to three as the dose climbs, and the most obvious before-and-after over months four to twelve. The big results come from staying on treatment, not the early weeks.
Are before and after photos of weight loss injections realistic?
They are motivating but selective, usually showing the far end near the finish line and flattered by lighting and posture. Results also differ by drug and dose. Comparing your early weeks to someone's later result on a different injection is not fair.
Which weight loss injection gives the best before and after?
On average, tirzepatide (Zepbound) produced the largest weight loss in trials, ahead of semaglutide (Wegovy) and then liraglutide (Saxenda). But the best result for you is the one you tolerate and stay on, supported by protein, activity, and time.
References
- 1.Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. SURMOUNT-1. NEJM 2022. Read on NEJM ↗
- 2.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. STEP 1. NEJM 2021. Read on NEJM ↗
- 3.Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. SCALE. NEJM 2015. Find on PubMed ↗
- 4.Reviews of comparative weight-loss efficacy of GLP-1 receptor agonists. Find on PubMed ↗
This article is general education, not medical advice. DoseLog is a tracking and reflection tool. Decisions about your medication, dose, and symptoms belong with a licensed clinician.
Keep reading